Cargando…

Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls

RATIONALE: The mechanisms underlying impaired sleep quality in insomnia are not fully known, but an important role for sleep fragmentation has been proposed. OBJECTIVES: The aim of this study is to explore potential mechanisms of sleep fragmentation influencing alterations of perceived sleep quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermans, Lieke W. A., Regis, Marta, Fonseca, Pedro, Overeem, Sebastiaan, Leufkens, Tim R. M., Vermeeren, Annemiek, van Gilst, Merel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794103/
https://www.ncbi.nlm.nih.gov/pubmed/32939597
http://dx.doi.org/10.1007/s00213-020-05660-3
_version_ 1783634137632997376
author Hermans, Lieke W. A.
Regis, Marta
Fonseca, Pedro
Overeem, Sebastiaan
Leufkens, Tim R. M.
Vermeeren, Annemiek
van Gilst, Merel M.
author_facet Hermans, Lieke W. A.
Regis, Marta
Fonseca, Pedro
Overeem, Sebastiaan
Leufkens, Tim R. M.
Vermeeren, Annemiek
van Gilst, Merel M.
author_sort Hermans, Lieke W. A.
collection PubMed
description RATIONALE: The mechanisms underlying impaired sleep quality in insomnia are not fully known, but an important role for sleep fragmentation has been proposed. OBJECTIVES: The aim of this study is to explore potential mechanisms of sleep fragmentation influencing alterations of perceived sleep quality. METHODS: We analyzed polysomnography (PSG) recordings from a double-blind crossover study with zopiclone 7.5 mg and placebo, in elderly participants with insomnia complaints and age-matched healthy controls. We compared survival dynamics of sleep and wake across group and treatment. Subsequently, we used a previously proposed model to estimate the amount of sleep onset latency (SOL) misperception from PSG-defined sleep fragmentation. Self-reported and model-estimated amount of SOL misperception were compared across group and treatment, as well as model prediction errors. RESULTS: In the zopiclone night, the average segment length of NREM sleep was increased (group F = 1.16, p = 0.32; treatment F = 8.89, p < 0.01; group x treatment F = 0.44, p = 0.65), while the segment length of wake was decreased (group F = 1.48, p = 0.23; treatment F = 11.49, p < 0.01; group x treatment F = 0.36, p = 0.70). The self-reported and model-estimated amount of SOL misperception were lower during the zopiclone night (self-reported group F = 6.08, p < 0.01, treatment F = 10.8, p < 0.01, group x treatment F = 2.49, p = 0.09; model-estimated F = 1.70, p = 0.19, treatment F = 16.1, p < 0.001, group x treatment F = 0.60, p = 0.55). The prediction error was not altered (group F = 1.62, p = 0.20; treatment F = 0.20, p = 0.65; group x treatment F = 1.01, p = 0.37). CONCLUSIONS: Impaired subjective sleep quality is associated with decreased NREM stability, together with increased stability of wake. Furthermore, we conclude that zopiclone-induced changes in SOL misperception can be largely attributed to predictable changes of sleep architecture.
format Online
Article
Text
id pubmed-7794103
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-77941032021-01-11 Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls Hermans, Lieke W. A. Regis, Marta Fonseca, Pedro Overeem, Sebastiaan Leufkens, Tim R. M. Vermeeren, Annemiek van Gilst, Merel M. Psychopharmacology (Berl) Original Investigation RATIONALE: The mechanisms underlying impaired sleep quality in insomnia are not fully known, but an important role for sleep fragmentation has been proposed. OBJECTIVES: The aim of this study is to explore potential mechanisms of sleep fragmentation influencing alterations of perceived sleep quality. METHODS: We analyzed polysomnography (PSG) recordings from a double-blind crossover study with zopiclone 7.5 mg and placebo, in elderly participants with insomnia complaints and age-matched healthy controls. We compared survival dynamics of sleep and wake across group and treatment. Subsequently, we used a previously proposed model to estimate the amount of sleep onset latency (SOL) misperception from PSG-defined sleep fragmentation. Self-reported and model-estimated amount of SOL misperception were compared across group and treatment, as well as model prediction errors. RESULTS: In the zopiclone night, the average segment length of NREM sleep was increased (group F = 1.16, p = 0.32; treatment F = 8.89, p < 0.01; group x treatment F = 0.44, p = 0.65), while the segment length of wake was decreased (group F = 1.48, p = 0.23; treatment F = 11.49, p < 0.01; group x treatment F = 0.36, p = 0.70). The self-reported and model-estimated amount of SOL misperception were lower during the zopiclone night (self-reported group F = 6.08, p < 0.01, treatment F = 10.8, p < 0.01, group x treatment F = 2.49, p = 0.09; model-estimated F = 1.70, p = 0.19, treatment F = 16.1, p < 0.001, group x treatment F = 0.60, p = 0.55). The prediction error was not altered (group F = 1.62, p = 0.20; treatment F = 0.20, p = 0.65; group x treatment F = 1.01, p = 0.37). CONCLUSIONS: Impaired subjective sleep quality is associated with decreased NREM stability, together with increased stability of wake. Furthermore, we conclude that zopiclone-induced changes in SOL misperception can be largely attributed to predictable changes of sleep architecture. Springer Berlin Heidelberg 2020-09-17 2021 /pmc/articles/PMC7794103/ /pubmed/32939597 http://dx.doi.org/10.1007/s00213-020-05660-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Investigation
Hermans, Lieke W. A.
Regis, Marta
Fonseca, Pedro
Overeem, Sebastiaan
Leufkens, Tim R. M.
Vermeeren, Annemiek
van Gilst, Merel M.
Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls
title Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls
title_full Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls
title_fullStr Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls
title_full_unstemmed Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls
title_short Assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls
title_sort assessing sleep-wake survival dynamics in relation to sleep quality in a placebo-controlled pharmacological intervention study with people with insomnia and healthy controls
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794103/
https://www.ncbi.nlm.nih.gov/pubmed/32939597
http://dx.doi.org/10.1007/s00213-020-05660-3
work_keys_str_mv AT hermansliekewa assessingsleepwakesurvivaldynamicsinrelationtosleepqualityinaplacebocontrolledpharmacologicalinterventionstudywithpeoplewithinsomniaandhealthycontrols
AT regismarta assessingsleepwakesurvivaldynamicsinrelationtosleepqualityinaplacebocontrolledpharmacologicalinterventionstudywithpeoplewithinsomniaandhealthycontrols
AT fonsecapedro assessingsleepwakesurvivaldynamicsinrelationtosleepqualityinaplacebocontrolledpharmacologicalinterventionstudywithpeoplewithinsomniaandhealthycontrols
AT overeemsebastiaan assessingsleepwakesurvivaldynamicsinrelationtosleepqualityinaplacebocontrolledpharmacologicalinterventionstudywithpeoplewithinsomniaandhealthycontrols
AT leufkenstimrm assessingsleepwakesurvivaldynamicsinrelationtosleepqualityinaplacebocontrolledpharmacologicalinterventionstudywithpeoplewithinsomniaandhealthycontrols
AT vermeerenannemiek assessingsleepwakesurvivaldynamicsinrelationtosleepqualityinaplacebocontrolledpharmacologicalinterventionstudywithpeoplewithinsomniaandhealthycontrols
AT vangilstmerelm assessingsleepwakesurvivaldynamicsinrelationtosleepqualityinaplacebocontrolledpharmacologicalinterventionstudywithpeoplewithinsomniaandhealthycontrols